Molecular basis of insulin action, Diabetes Metab, vol.24, pp.477-489, 1998. ,
PTEN and the PI3-Kinase Pathway in Cancer, Annual Review of Pathology: Mechanisms of Disease, vol.4, issue.1, pp.127-150, 2009. ,
DOI : 10.1146/annurev.pathol.4.110807.092311
Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit, J Biol Chem, vol.268, pp.9478-9483, 1993. ,
PTEN: The down side of PI 3-kinase signalling, Cellular Signalling, vol.14, issue.4, pp.285-295, 2002. ,
DOI : 10.1016/S0898-6568(01)00234-0
Targeting PI3K signalling in cancer: opportunities, challenges and limitations, Nature Reviews Cancer, vol.16, issue.8, pp.550-562, 2009. ,
DOI : 10.1038/nrc2664
Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation, PLoS ONE, vol.5, issue.3, p.9646, 2010. ,
DOI : 10.1371/journal.pone.0009646.s010
Stable Activation of Phosphatidylinositol 3-Kinase in the T Cell Immunological Synapse Stimulates Akt Signaling to FoxO1 Nuclear Exclusion and Cell Growth Control, The Journal of Immunology, vol.174, issue.7, 2005. ,
DOI : 10.4049/jimmunol.174.7.4161
Imaging antigen-induced PI3K activation in T cells, Nature Immunology, vol.3, issue.11, pp.1090-1096, 2002. ,
DOI : 10.1038/ni847
Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2, PLoS ONE, vol.49, issue.Pt 3, p.41992, 2012. ,
DOI : 10.1371/journal.pone.0041992.s002
O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor ?? Expression and Confer Resistance to 4-OH-Tamoxifen in Human Breast Cancer-Derived MCF-7 Cells, PLoS ONE, vol.29, issue.7, pp.69150-9539, 2013. ,
DOI : 10.1371/journal.pone.0069150.s004
URL : https://hal.archives-ouvertes.fr/hal-00866032
Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer, Biochemical Pharmacology, vol.76, issue.7, pp.873-883, 2008. ,
DOI : 10.1016/j.bcp.2008.07.027
Implication of protein tyrosine phosphatase 1B in MCF-7 cell proliferation and resistance to 4-OH tamoxifen, Biochemical and Biophysical Research Communications, vol.387, issue.4, pp.748-753, 2009. ,
DOI : 10.1016/j.bbrc.2009.07.105
Priority paper Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway, European Journal of Biochemistry, vol.258, issue.1, pp.271-276, 1998. ,
DOI : 10.1046/j.1432-1327.1998.2580271.x
Isoproterenol Inhibits Insulin-Stimulated Tyrosine Phosphorylation of the Insulin Receptor Without Increasing its Serine/Threonine Phosphorylation, European Journal of Biochemistry, vol.4, issue.1, pp.108-115, 1995. ,
DOI : 10.1210/jc.77.1.73
Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer, Mol Pharmacol, vol.60, pp.640-645, 2001. ,
Interaction of the Insulin Receptor with the Receptor-Like Protein Tyrosine Phosphatases PTP?? and PTP?? in Living Cells, Molecular Pharmacology, vol.67, issue.4, pp.1206-1213, 2005. ,
DOI : 10.1124/mol.104.009514
Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptor, EMBO reports, vol.13, pp.512-518, 2006. ,
DOI : 10.1074/jbc.M208518200
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites, PLoS ONE, vol.5, issue.3, p.9540, 2010. ,
DOI : 10.1371/journal.pone.0009540.t001
Cetuximab and biomarkers in non-smallcell lung carcinoma, Biologics, vol.6, pp.221-231, 2012. ,
Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941, Cancer Cell, vol.15, issue.5, pp.429-440, 2009. ,
DOI : 10.1016/j.ccr.2009.03.020
In vitro comparative evaluation of trastuzumab (Herceptin(R)) combined with paclitaxel (Taxol(R)) or docetaxel (Taxotere(R)) in HER2-expressing human breast cancer cell lines, Annals of Oncology, vol.13, issue.11, pp.1743-1748, 2002. ,
DOI : 10.1093/annonc/mdf263
Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer, Mol Pharmacol, vol.68, pp.885-894, 2005. ,
A New Highly Efficient Substrate-trapping Mutant of Protein Tyrosine Phosphatase 1B (PTP1B) Reveals Full Autoactivation of the Insulin Receptor Precursor, Journal of Biological Chemistry, vol.286, issue.22, pp.19373-19380, 2011. ,
DOI : 10.1074/jbc.M111.222984
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one (LY294002), J Biol Chem, vol.269, pp.5241-5248, 1994. ,
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains, Proceedings of the National Academy of Sciences, vol.107, issue.46, pp.20126-20131, 2010. ,
DOI : 10.1073/pnas.1004522107
Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention, Breast Cancer Research and Treatment, vol.29, issue.3, pp.209-217, 1998. ,
DOI : 10.1023/A:1005950916707
O-GlcNAcylation of FoxO1 in pancreatic ?? cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism, The FASEB Journal, vol.28, issue.2, pp.1010-1021, 2014. ,
DOI : 10.1096/fj.13-238378
URL : https://hal.archives-ouvertes.fr/hal-01123110
Effect of Epidermal Growth Factor on Phosphatidylinositol 3-kinase Activity in Rabbit Corneal Epithelial Cells, Experimental Eye Research, vol.63, issue.3, pp.265-275, 1996. ,
DOI : 10.1006/exer.1996.0115
Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination, Proceedings of the National Academy of Sciences, vol.108, issue.16, pp.6486-6491, 2011. ,
DOI : 10.1073/pnas.1019062108
Insulin-like Growth Factor Receptor Levels Are Regulated by Cell Density and by Long Term Estrogen Deprivation in MCF7 Human Breast Cancer Cells, Journal of Biological Chemistry, vol.276, issue.43, pp.40080-40086, 2001. ,
DOI : 10.1074/jbc.M105892200
Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells, British Journal of Pharmacology, vol.3, issue.10, pp.2391-2400, 1995. ,
DOI : 10.1111/j.1476-5381.1995.tb15085.x
Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells., Proceedings of the National Academy of Sciences, vol.83, issue.4, pp.991-995, 1986. ,
DOI : 10.1073/pnas.83.4.991
Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture, Cancer Res, vol.42, pp.4394-4398, 1982. ,
Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein, Cancer Res, vol.54, pp.4703-4709, 1994. ,
Insulin receptor expression and function in human breast cancer cell lines, Cancer Res, vol.52, pp.3924-3930, 1992. ,
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling, Clin Cancer Res, vol.5, pp.1935-1944, 1999. ,
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity, Biochemical Journal, vol.290, issue.2, pp.419-426, 1993. ,
DOI : 10.1042/bj2900419
Monitoring the Activation State of Insulin/Insulin-Like Growth Factor-1 Hybrid Receptors Using Bioluminescence Resonance Energy Transfer, Molecular Pharmacology, vol.70, issue.5, pp.1802-1811, 2006. ,
DOI : 10.1124/mol.106.026989
Hybrid Receptors Formed by Insulin Receptor (IR) and Insulin-like Growth Factor I Receptor (IGF-IR) Have Low Insulin and High IGF-1 Affinity Irrespective of the IR Splice Variant, Journal of Biological Chemistry, vol.281, issue.36, pp.25869-25874, 2006. ,
DOI : 10.1074/jbc.M605189200
Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol, Cancer Res, vol.48, pp.4083-4092, 1988. ,
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions, Embo J, vol.15, pp.2452-2467, 1996. ,
Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor, Journal of Biological Chemistry, vol.274, issue.42, pp.30169-30181, 1999. ,
DOI : 10.1074/jbc.274.42.30169
Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factorinduced mitogenic and survival signaling by multiple positive feedback loops, 2006. ,
Sensitivity control through attenuation of signal transfer efficiency by negative regulation of cellular signalling, Nature Communications, vol.22, p.743, 2011. ,
DOI : 10.1038/ncomms1745
Targeting the ERBB family in cancer: couples therapy, Nature Reviews Cancer, vol.5, issue.9, pp.663-673, 2013. ,
DOI : 10.1038/nrc3559
Targeting PI3K in Cancer: Any Good News?, Frontiers in Oncology, vol.3, p.108, 2013. ,
DOI : 10.3389/fonc.2013.00108
In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKT, Cancer Research, vol.69, issue.12, pp.5073-5081, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-3839
The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane, Cell Death and Differentiation, vol.8, issue.11, pp.1795-1804, 2010. ,
DOI : 10.1083/jcb.200212113
Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer, Molecular and Cellular Endocrinology, vol.316, issue.1, pp.86-92, 2010. ,
DOI : 10.1016/j.mce.2009.09.012
URL : https://hal.archives-ouvertes.fr/hal-00550178
Insulin and insulin-like growth factor signalling in neoplasia, Nature Reviews Cancer, vol.5, issue.12, pp.915-928, 2008. ,
DOI : 10.2174/156800907781386623
Modulation of Direct Leptin Signaling by Soluble Leptin Receptor, Molecular Endocrinology, vol.18, issue.6, pp.1354-1362, 2004. ,
DOI : 10.1210/me.2004-0027
Mutations in the Human Leptin and Leptin Receptor Genes as Models of Serum Leptin Receptor Regulation, Diabetes, vol.51, issue.6, pp.1980-1985, 2002. ,
DOI : 10.2337/diabetes.51.6.1980
Purification and characterization of a novel soluble receptor for interleukin 1, Journal of Experimental Medicine, vol.174, issue.5, pp.1251-1254, 1991. ,
DOI : 10.1084/jem.174.5.1251
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins, Endocrine Reviews, vol.23, issue.6, pp.824-854, 2002. ,
DOI : 10.1210/er.2001-0033
Insulinlike growth factor-binding proteins (IGFBPs) and their regulatory dynamics, 1996. ,
Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulinlike growth factor (IGF) I and II, IGF-binding proteins (IGFBPs, p.3, 1996. ,
Correlation between insulin-like growth factor binding protein-3 serum level and melanoma progression, Journal of the American Academy of Dermatology, vol.64, issue.5, pp.865-872, 2011. ,
DOI : 10.1016/j.jaad.2010.03.035
Biotransformation of insulin glargine after subcutaneous injection in healthy subjects, Current Medical Research and Opinion, vol.19, issue.1, pp.34-40, 2003. ,
DOI : 10.1185/030079902125001416
Glargine blood biotransformation: in??vitro appraisal with human insulin immunoassay, Diabetes & Metabolism, vol.33, issue.3, pp.205-212, 2007. ,
DOI : 10.1016/j.diabet.2006.12.002
Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes, Diabetes Care, vol.35, issue.12, pp.2626-2630, 2012. ,
DOI : 10.2337/dc12-0270
) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells, Archives of Physiology and Biochemistry, vol.67, issue.2, pp.73-78, 2010. ,
DOI : 10.1002/dmrr.912